|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23 TWD | +1.32% |
|
+2.22% | +3.60% |
| 04-08 | Feng Chi Biotech Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | Feng Chi Biotech Corp. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Feng Chi Biotech Corp. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was TWD 180.58 million compared to TWD 193.46 million a year ago.
Net income was TWD 22.79 million compared to TWD 24.61 million a year ago. Basic earnings per share from continuing operations was TWD 1.48 compared to TWD 1.6 a year ago. Diluted earnings per share from continuing operations was TWD 1.47 compared to TWD 1.6 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +3.60% | 10.98M | |
| -14.24% | 271M | |
| +9.01% | 197M | |
| +27.11% | 70.15M |
FENG CHI BIOTECH CORP. 
